Factor XI in haemostasis and thrombosis: Past, present and future

作者: Uri Seligsohn

DOI: 10.1160/TH07-04-0246

关键词:

摘要: Thromb Haemost 2007; 98: 84–89 The discipline of haemostasis and thrombosis has set an example, perhaps more than other disciplines Medicine, in discoveries based on observations the so called “experiments nature”. During a relatively short time 13 years (1947 – 1960), most coagulation factors were identified patients who presented with bleeding tendency worked up by rather simple laboratory assays.This era was followed characterization biochemical reactions involved blood coagulation, delineation sequence pathways recently unraveling molecular genetic aspects various components. objective this review is to describe some major developments understanding role factor (F)XI that have occurred over 50 research, highlight recent evidence which suggests FXI deficiency can antithrombotic effect.

参考文章(57)
Hava Peretz, Avital Mulai, Sali Usher, Ariella Zivelin, Avihai Segal, Zahavi Weisman, Moshe Mittelman, Hannah Lupo, Naomi Lanir, Benjamin Brenner, Ofer Shpilberg, Uri Seligsohn, The Two Common Mutations Causing Factor XI Deficiency in Jews Stem From Distinct Founders: One of Ancient Middle Eastern Origin and Another of More Recent European Origin Blood. ,vol. 90, pp. 2654- 2659 ,(1997) , 10.1182/BLOOD.V90.7.2654
SAMUEL I. RAPAPORT, ROBERT R. PROCTOR, MARY JANE PATCH, MAURICE YETTRA, The mode of inheritance of PTA deficiency: evidence for the existence of major PTA deficiency and minor PTA deficiency. Blood. ,vol. 18, pp. 149- 165 ,(1961) , 10.1182/BLOOD.V18.2.149.149
O Shpilberg, H Peretz, A Zivelin, R Yatuv, A Chetrit, T Kulka, C Stern, E Weiss, U Seligsohn, One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood. ,vol. 85, pp. 429- 432 ,(1995) , 10.1182/BLOOD.V85.2.429.429
X. WANG, Q. CHENG, L. XU, G. Z. FEUERSTEIN, M-Y. HSU, P. L. SMITH, D. A. SEIFFERT, W. A. SCHUMACHER, M. L. OGLETREE, D. GAILANI, Effects of factor IX or factor XI deficiency on ferric chloride‐induced carotid artery occlusion in mice Journal of Thrombosis and Haemostasis. ,vol. 3, pp. 695- 702 ,(2005) , 10.1111/J.1538-7836.2005.01236.X
Mattanja Triemstra, Frits R Rosendaal, Cees Smit, Henk M Van der Ploeg, Ernest Briet, Mortality in Patients with Hemophilia: Changes in a Dutch Population from 1986 to 1992 and 1973 to 1986 Annals of Internal Medicine. ,vol. 123, pp. 823- 827 ,(1995) , 10.7326/0003-4819-123-11-199512010-00002
O. Shpilberg, I. Rabi, K. Schiller, R. Walden, D. Harats, K.S. Tyrrell, B. Coller, U. Seligsohn, Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein αIIbβ3 (GPIIb/IIIa) and αvβ3 Receptors Are Not Protected From Atherosclerosis Circulation. ,vol. 105, pp. 1044- 1048 ,(2002) , 10.1161/HC0902.104676
B N Bouma, H ten Cate, M C Minnema, P W Friederich, M Levi, P A von dem Borne, L O Mosnier, J C Meijers, B J Biemond, C E Hack, Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor. Journal of Clinical Investigation. ,vol. 101, pp. 10- 14 ,(1998) , 10.1172/JCI781